Publicaciones en colaboración con investigadores/as de University of Melbourne (9)

2023

  1. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1370-1375

  2. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1376-1382

  3. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

    Annals of Oncology, Vol. 34, Núm. 4, pp. 397-409

2020

  1. Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

    Breast Cancer Research and Treatment, Vol. 184, Núm. 2, pp. 421-431

2018

  1. Tailoring adjuvant endocrine therapy for premenopausal breast cancer

    New England Journal of Medicine, Vol. 379, Núm. 2, pp. 122-137

2016

  1. Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial

    Journal of Clinical Oncology, Vol. 34, Núm. 14, pp. 1601-1610

  2. Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): The SOFT-EST substudy

    Journal of Clinical Oncology, Vol. 34, Núm. 14, pp. 1584-1593

2015

  1. Adjuvant ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 372, Núm. 5, pp. 436-446

2014

  1. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 371, Núm. 2, pp. 107-118